Paulk, P. Barrett
Eloubeidi, Dala
Johnson, Mark
Swain, Thomas
Mason, John O. III
Curcio, Christine A.
Crosson, Jason N.
Article History
Received: 16 December 2021
Accepted: 30 November 2022
First Online: 6 December 2022
Declarations
:
: Institutional Review Board (IRB) approval was obtained prior to collection of patient data from the University of Alabama-Birmingham IRB. The study conducted is HIPAA compliant and adhered to the tenets of the Declaration of Helsinki. Informed consent for study participation was waived by the University of Alabama-Birmingham IRB because of the retrospective nature of the already existing data utilized in this study. The study was determined to be minimal risk, could not have practically been carried out without the waiver, and in no way could have adversely affected the rights or welfare of subjects.
: Not applicable.
: None of the authors have any financial or non-financial competing interests.